Identification of a Novel TSC2 c.170G>A Missense Variant: A Case Report and Elaboration on the Yield of Targeted Options against Tuberous Sclerosis Complex Manifestations.
Georgios I PapageorgiouNikolaos SkouterisChristos ValavanisGabriela-Monica StancEfthymia SoukaNikolaos CharalampakisPublished in: Reviews on recent clinical trials (2023)
As novel pathogenic variants of TSC genes are constantly being explored, the identification of TSC variants of unknown significance in combination with absent clinical diagnostic criteria cannot exclude a TSC diagnosis. We support the implementation of clinical judgment in assisting the diagnosis of TSC, as well as the enrollment of patients in clinical trials due to the rarity of the disease.
Keyphrases
- clinical trial
- end stage renal disease
- bioinformatics analysis
- ejection fraction
- copy number
- newly diagnosed
- chronic kidney disease
- healthcare
- primary care
- genome wide
- peritoneal dialysis
- randomized controlled trial
- prognostic factors
- autism spectrum disorder
- open label
- quality improvement
- study protocol
- patient reported
- genome wide identification